Medical Science News

RSS

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

5 Jun 2021

Maternal SARS-CoV-2 infection imprints immune response in the newborn

A new bioRxiv* preprint reports the immunological footprint in the newborn left by maternal infection with SARS-CoV-2 during pregnancy.

4 Jun 2021

Risk of SARS-CoV-2 spread to bats

A recent bioRxiv* preprint offers a powerful risk assessment approach to estimate the risk of bat exposure to SARS-CoV-2 from humans during their interactions in the wild.

4 Jun 2021

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

In a new study by researchers in the UK, Germany and South Africa, this process is visualized using time-lapse microscopy of a human cell lung line, demonstrating that SARS-CoV-2 can induce cell-to-cell fusion within 6 hours post-infection. Further, the application of neutralizing monoclonal antibodies or convalescent plasma was unable to prevent the spread of the virus by this mechanism, suggesting that removing SARS-CoV-2 from cells permissive of cell membrane fusion could be more difficult than other types of cell.

4 Jun 2021

Post-COVID-19 assessment shows long-lasting consequences for many non-hospitalized individuals

Complications following COVID-19 infection require quick identification and management to help plan policy and health system responses. Researchers in the UK recently described the 12-month experience of the first dedicated post-COVID clinical service in the UK to include both hospitalized and non-hospitalized COVID-19 patients. This study has been released on the medRxiv* the preprint server.

4 Jun 2021

Mental health effects common among mild and severe cases of COVID-19

Findings on mental health outcomes of COVID-19 infection show frequent symptoms associated with lasting neurological symptoms.

4 Jun 2021

New scientific evidence supports the health benefits of superfoods

Researchers will be presenting their findings at the NUTRITION 2021 LIVE ONLINE conference on the science behind the health benefits of certain superfoods.

4 Jun 2021

Anti-inflammatory diets could help lower the risk of breast cancer

Women eating more foods that increase inflammation in the body have a 12% increase in their risk of breast cancer relative to women who did not.

4 Jun 2021

A lack of oversight for unproven stem cell interventions is a global public health problem

Authors are urging the WHO to establish an Exert Advisory Committee on Regenerative Medicine to provide harmony to the national regulations on the SCI industry.

4 Jun 2021

Research reveals paternal transmission of stress responses to offspring via sperm

Male mice more susceptible to stress can pass down their behaviors to offspring via changes in their sperm’s genetic code, according to new research published in JNeurosci.

4 Jun 2021

Researchers identify a novel link between aging, metabolism and anti-cancer T-cell function

MUSC Hollings Cancer Center researchers are finding solutions to the aging-related changes that reduce anti-cancer immunity. Besim Ogretmen, Ph.D., and colleagues found a novel link between aging, metabolism and anti-cancer T-cell function. Their work, published in Cell Reports, sheds light on an important pathway that cannot be ignored during cancer treatment.

4 Jun 2021

New book addresses relationships between firing-rate dynamics and developmental stages

What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.

4 Jun 2021

New study undermines the link between neural electrical activity and free will

For decades, researchers have debated whether the buildup of certain electrical activities in the brain indicates that human beings are unable to act out of free will.

4 Jun 2021

New biomaterial for pancreatic islet transplants does not trigger the body's immune response

A multidisciplinary research team led by Jonathan Lakey, Ph.D., professor of surgery and biomedical engineering at the University of California, Irvine, has developed a biomaterial for pancreatic islet transplants that doesn't trigger the body's immune response.

4 Jun 2021

Secondary infections amplify the brain's immune response and affect memory in Alzheimer's disease

New research into Alzheimer's disease (AD) suggests that secondary infections and new inflammatory events amplify the brain's immune response and affect memory in mice and in humans - even when these secondary events occur outside the brain.

3 Jun 2021

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

Following the Food and Drug Administration's approval, UC San Diego Health is the first designated medical center in San Diego certified to offer a new immunotherapy treatment of multiple myeloma outside of a clinical trial.

3 Jun 2021

NIH study identifies promising oral antiviral treatment for COVID-19

The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.

3 Jun 2021

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Airway mucus consists of various proteins such as long mucins MUC5AC and MUC5B, both of which contribute greatly to the proper gel-like consistency of this most essential bodily fluid.

3 Jun 2021

Could a green tea compound combat SARS-CoV-2?

Researchers recently published an article that reviewed the mechanisms by which EGCG could inhibit SARS-CoV-2 infection and the various syndromes caused by COVID-19.

3 Jun 2021

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.

3 Jun 2021

Medical Science News

Study finds no genetic evidence to prove vitamin D protects against coronavirus

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Risk of SARS-CoV-2 spread to bats

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

Post-COVID-19 assessment shows long-lasting consequences for many non-hospitalized individuals

Mental health effects common among mild and severe cases of COVID-19

New scientific evidence supports the health benefits of superfoods

Anti-inflammatory diets could help lower the risk of breast cancer

A lack of oversight for unproven stem cell interventions is a global public health problem

Research reveals paternal transmission of stress responses to offspring via sperm

Researchers identify a novel link between aging, metabolism and anti-cancer T-cell function

New book addresses relationships between firing-rate dynamics and developmental stages

New study undermines the link between neural electrical activity and free will

New biomaterial for pancreatic islet transplants does not trigger the body's immune response

Secondary infections amplify the brain's immune response and affect memory in Alzheimer's disease

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

NIH study identifies promising oral antiviral treatment for COVID-19

Lung protein hyperconcentration may be a key factor in predicting COPD risks

Could a green tea compound combat SARS-CoV-2?

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News